- Home
- CTSO vs RGT Comparison
CTSO vs RGT Comparison
Compare CTSO & RGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- RGT
- Stock Information
- Founded
- CTSO 1997
- RGT 1986
- Country
- CTSO United States
- RGT United States
- Employees
- CTSO N/A
- RGT N/A
- Industry
- CTSO Medical/Dental Instruments
- RGT Trusts Except Educational Religious and Charitable
- Sector
- CTSO Health Care
- RGT Finance
- Exchange
- CTSO Nasdaq
- RGT Nasdaq
- Market Cap
- CTSO 72.8M
- RGT 80.2M
- IPO Year
- CTSO N/A
- RGT N/A
- Fundamental
- Price
- CTSO $0.89
- RGT $12.36
- Analyst Decision
- CTSO Buy
- RGT
- Analyst Count
- CTSO 2
- RGT 0
- Target Price
- CTSO $5.50
- RGT N/A
- AVG Volume (30 Days)
- CTSO 351.0K
- RGT 22.4K
- Earning Date
- CTSO 08-07-2025
- RGT 01-01-0001
- Dividend Yield
- CTSO N/A
- RGT 1.43%
- EPS Growth
- CTSO N/A
- RGT N/A
- EPS
- CTSO N/A
- RGT 0.92
- Revenue
- CTSO $36,107,520.00
- RGT N/A
- Revenue This Year
- CTSO $11.15
- RGT N/A
- Revenue Next Year
- CTSO $21.39
- RGT N/A
- P/E Ratio
- CTSO N/A
- RGT $11.42
- Revenue Growth
- CTSO 20.18
- RGT N/A
- 52 Week Low
- CTSO $0.71
- RGT $7.84
- 52 Week High
- CTSO $1.61
- RGT $11.08
- Technical
- Relative Strength Index (RSI)
- CTSO 41.50
- RGT 55.29
- Support Level
- CTSO $1.03
- RGT $12.22
- Resistance Level
- CTSO $1.19
- RGT $12.49
- Average True Range (ATR)
- CTSO 0.09
- RGT 0.11
- MACD
- CTSO 0.01
- RGT 0.00
- Stochastic Oscillator
- CTSO 27.21
- RGT 64.38
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About RGT Royce Global Value Trust Inc.
Royce Global Value Trust Inc is a diversified closed-end investment company. The fund spreads its investments across diversified sectors such as information technology, consumer discretionary, health care, materials, consumer staples, and energy. Geographically, it has presence in the region of the United Kingdom, Japan, the United States, Canada, France, Hong Kong, and Germany.